SEC Info - Intellia Therapeutics, Inc. - ‘8-K’ for 3/26/20

SEC Info℠

Home

Help

Please Sign In

Intellia Therapeutics, Inc. – ‘8-K’ for 3/26/20 – ‘XML’

On: Thursday, 3/26/20, at 6:15am ET · For: 3/26/20 · Accession #: 1564590-20-12963 · File #: 1-37766

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/26/20  Intellia Therapeutics, Inc.       8-K:8       3/26/20   10:177K                                   ActiveDisclosure/FA

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     40K 
 9: R1          Document and Entity Information                     HTML     49K 
 6: XML         IDEA XML File -- Filing Summary                      XML     11K 
 8: XML         XBRL Instance -- ntla-8k_20200326_htm                XML     14K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- ntla-20200326_lab                     XML     58K 
 4: EX-101.PRE  XBRL Presentations -- ntla-20200326_pre              XML     35K 
 2: EX-101.SCH  XBRL Schema -- ntla-20200326                         XSD     18K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
 5: ZIP         XBRL Zipped Folder -- 0001564590-20-012963-xbrl      Zip     12K

‘XML’ — XBRL Instance — ntla-8k_20200326_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="ntla-20200326.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

<dei:AmendmentFlag contextRef="C_0001652130_20200227_20200227" id="F_000002"> false </dei:AmendmentFlag>

<dei:EntityCentralIndexKey contextRef="C_0001652130_20200227_20200227" id="F_000003"> 0001652130 </dei:EntityCentralIndexKey>

<dei:DocumentType contextRef="C_0001652130_20200227_20200227" id="F_000001"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="C_0001652130_20200227_20200227" id="F_000004"> 2020-03-26 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="C_0001652130_20200227_20200227" id="F_000000"> INTELLIA THERAPEUTICS, INC. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="C_0001652130_20200227_20200227" id="F_000007"> DE </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="C_0001652130_20200227_20200227" id="F_000006"> 001-37766 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="C_0001652130_20200227_20200227" id="F_000008"> 36-4785571 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="C_0001652130_20200227_20200227" id="F_000009"> 40 Erie Street </dei:EntityAddressAddressLine1>

<dei:EntityAddressAddressLine2 contextRef="C_0001652130_20200227_20200227" id="F_000010"> Suite 130 </dei:EntityAddressAddressLine2>

<dei:EntityAddressCityOrTown contextRef="C_0001652130_20200227_20200227" id="F_000011"> Cambridge </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="C_0001652130_20200227_20200227" id="F_000012"> MA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="C_0001652130_20200227_20200227" id="F_000013"> 02139 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="C_0001652130_20200227_20200227" id="F_000014"> (857) </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="C_0001652130_20200227_20200227" id="F_000015"> 285-6200 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="C_0001652130_20200227_20200227" id="F_000016"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="C_0001652130_20200227_20200227" id="F_000017"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="C_0001652130_20200227_20200227" id="F_000018"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="C_0001652130_20200227_20200227" id="F_000019"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="C_0001652130_20200227_20200227" id="F_000020"> Common Stock (Par Value $0.0001) </dei:Security12bTitle>

<dei:TradingSymbol contextRef="C_0001652130_20200227_20200227" id="F_000021"> NTLA </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="C_0001652130_20200227_20200227" id="F_000022"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="C_0001652130_20200227_20200227" id="F_000005"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/01/22  Intellia Therapeutics, Inc.       424B5                  2:526K                                   Donnelley … Solutions/FA
 3/04/22  Intellia Therapeutics, Inc.       424B5                  2:547K                                   Donnelley … Solutions/FA
 7/01/21  Intellia Therapeutics, Inc.       424B5                  1:604K                                   Donnelley … Solutions/FA
 6/28/21  Intellia Therapeutics, Inc.       424B5                  1:601K                                   Donnelley … Solutions/FA
12/02/20  Intellia Therapeutics, Inc.       424B5                  1:586K                                   Donnelley … Solutions/FA
11/30/20  Intellia Therapeutics, Inc.       424B5                  1:585K                                   Donnelley … Solutions/FA
11/30/20  Intellia Therapeutics, Inc.       S-3ASR     11/30/20    5:913K                                   Donnelley … Solutions/FA

↑Top